OpenURL Connection Search

Select item for more details and to access through your institution.

Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-α, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy?
Published in:
Internal Medicine Journal, 2001, v. 31, n. 3, p. 146, doi. 10.1046/j.1445-5994.2001.00039.x
By:
- Mortimore, M.;
- Gibson, P. R.;
- Selby, W. S.;
- Radford-Smith, G. L.;
- Florin, T. H. J.
Publication type:
Article
Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease.
Published in:
Internal Medicine Journal, 2014, v. 44, n. 5, p. 490, doi. 10.1111/imj.12402
By:
- Wright, E. K.;
- Williams, J.;
- Andrews, J. M.;
- Day, A. S.;
- Gearry, R. B.;
- Bampton, P.;
- Moore, D.;
- Lemberg, D.;
- Ravikumaran, R.;
- Wilson, J.;
- Lewindon, P.;
- Radford‐Smith, G.;
- Rosenbaum, J.;
- Catto‐Smith, A.;
- Desmond, P. V.;
- Connell, W. R.;
- Cameron, D.;
- Alex, G.;
- Bell, S. J.;
- De Cruz, P.
Publication type:
Article
An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity.
Published in:
Mucosal Immunology (1933-0219), 2011, v. 4, n. 3, p. 354, doi. 10.1038/mi.2010.74
By:
- Eri, R. D.;
- Adams, R. J.;
- Tran, T. V.;
- Tong, H.;
- Das, I.;
- Roche, D. K.;
- Oancea, I.;
- Png, C. W.;
- Jeffery, P. L.;
- Radford-Smith, G. L.;
- Cook, M. C.;
- Florin, T. H.;
- McGuckin, M. A.
Publication type:
Article
Drain fluid amylase as a sensitive biomarker for the early detection of anastomotic leakage in ileal pouch surgery.
Published in:
Colorectal Disease, 2019, v. 21, n. 4, p. 460, doi. 10.1111/codi.14536
By:
- Clark, D. A.;
- Cuda, T.;
- Riddell, A.;
- Radford‐Smith, G.;
- Solomon, M.
Publication type:
Article
Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy.
Published in:
Colorectal Disease, 2013, v. 15, n. 3, p. 374, doi. 10.1111/j.1463-1318.2012.03188.x
By:
- Powar, M. P.;
- Martin, P.;
- Croft, A. R.;
- Walsh, A.;
- Petersen, D.;
- Stevenson, A. R. L.;
- Lumley, J. W.;
- Stitz, R. W.;
- Radford‐Smith, G. L.;
- Clark, D. A.
Publication type:
Article
The effect of interleukin-10 and transforming growth factor beta-1 on HLA-DR expression in colonic epithelial cells.
Published in:
Mediators of Inflammation, 1998, v. 7, n. 1, p. 7, doi. 10.1080/09629359891315
By:
- Zimmerman, M. J.;
- Radford-Smith, G. R.;
- Jewell, D. P.
Publication type:
Article
BT07P AN EMERGING TECHNIQUE IN BARIATRIC SURGERY, IN AN UNUSUAL PATIENT COHORT.
Published in:
ANZ Journal of Surgery, 2009, v. 79, p. A3, doi. 10.1111/j.1445-2197.2009.04912_7.x
By:
- Macgregor, D. E.;
- Hopkins, G.;
- Radford-Smith, G.
Publication type:
Article
Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2006, v. 23, n. 7, p. 1017, doi. 10.1111/j.1365-2036.2006.02861.x
By:
- GIBSON, P. R.;
- FIXA, B.;
- PEKÁRKOVÁ, B.;
- BÁTOVSKÝ, M.;
- RADFORD‐SMITH, G.;
- TIBITANZL, J.;
- GABALEC, L.;
- FLORIN, T. H. J.;
- GREINWALD, R.
Publication type:
Article
CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, for steroid-dependent Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2006, v. 23, n. 5, p. 617, doi. 10.1111/j.1365-2036.2006.02791.x
By:
- FEAGAN, B. G.;
- SANDBORN, W. J.;
- LICHTENSTEIN, G.;
- RADFORD‐SMITH, G.;
- PATEL, J.;
- INNES, A.
Publication type:
Article
Editorial: first among Equals—not for either infliximab or adalimumab in Crohn's disease—yet.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 8, p. 1225, doi. 10.1111/apt.14549
By:
- Lim, M. H.;
- Doecke, J. D.;
- Radford‐Smith, G. L.
Publication type:
Article
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1037, doi. 10.1111/apt.14368
By:
- Mitrev, N.;
- Vande Casteele, N.;
- Seow, C. H.;
- Andrews, J. M.;
- Connor, S. J.;
- Moore, G. T.;
- Barclay, M.;
- Begun, J.;
- Bryant, R.;
- Chan, W.;
- Corte, C.;
- Ghaly, S.;
- Lemberg, D. A.;
- Kariyawasam, V.;
- Lewindon, P.;
- Martin, J.;
- Mountifield, R.;
- Radford‐Smith, G.;
- Slobodian, P.;
- Sparrow, M.
Publication type:
Article
Editorial: faecal microbiota transplantation for ulcerative colitis-not quite there yet?
Published in:
2017
By:
- Lim, M. H.;
- Radford-Smith, G. L.
Publication type:
Editorial
Editorial: relative efficacy of infliximab and adalimumab in Crohn's disease in an Australian and New Zealand cohort - authors' reply.
Published in:
2017
By:
- Radford‐Smith, G. L.;
- Hartnell, F.;
- Doecke, J. D.
Publication type:
Editorial
Review article: acute severe ulcerative colitis - evidence-based consensus statements.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 2, p. 127, doi. 10.1111/apt.13670
By:
- Chen, J.‐H.;
- Andrews, J. M.;
- Kariyawasam, V.;
- Moran, N.;
- Gounder, P.;
- Collins, G.;
- Walsh, A. J.;
- Connor, S.;
- Lee, T. W. T.;
- Koh, C. E.;
- Chang, J.;
- Paramsothy, S.;
- Tattersall, S.;
- Lemberg, D. A.;
- Radford‐Smith, G.;
- Lawrance, I. C.;
- McLachlan, A.;
- Moore, G. T.;
- Corte, C.;
- Katelaris, P.
Publication type:
Article
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 7, p. 867, doi. 10.1111/apt.13353
By:
- De Cruz, P.;
- Kamm, M. A.;
- Hamilton, A. L.;
- Ritchie, K. J.;
- Krejany, E. O.;
- Gorelik, A.;
- Liew, D.;
- Prideaux, L.;
- Lawrance, I. C.;
- Andrews, J. M.;
- Bampton, P. A.;
- Jakobovits, S.;
- Florin, T. H.;
- Gibson, P. R.;
- Debinski, H.;
- Gearry, R. B.;
- Macrae, F. A.;
- Leong, R. W.;
- Kronborg, I.;
- Radford‐Smith, G.
Publication type:
Article
Commentary: salvage medical therapy for acute severe colitis - ciclosporin or infliximab? Author's reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 8, p. 989, doi. 10.1111/apt.12475
By:
- Croft, A.;
- Walsh, A.;
- Doecke, J.;
- Radford‐Smith, G.
Publication type:
Article
Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided; authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 8, p. 993, doi. 10.1111/apt.12474
By:
- Croft, A.;
- Walsh, A.;
- Doecke, J.;
- Radford‐Smith, G.
Publication type:
Article
Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 3, p. 294, doi. 10.1111/apt.12375
By:
- Croft, A.;
- Walsh, A.;
- Doecke, J.;
- Cooley, R.;
- Howlett, M.;
- Radford‐Smith, G.
Publication type:
Article

Found: 18